Skip to main content
Erschienen in: Supportive Care in Cancer 6/2013

01.06.2013 | Original Article

Predictive factors for overall quality of life in patients with advanced cancer

verfasst von: Gemma Cramarossa, Edward Chow, Liying Zhang, Gillian Bedard, Liang Zeng, Arjun Sahgal, Vassilios Vassiliou, Takefumi Satoh, Palmira Foro, Brigette B. Y. Ma, Wei-Chu Chie, Emily Chen, Henry Lam, Andrew Bottomley

Erschienen in: Supportive Care in Cancer | Ausgabe 6/2013

Einloggen, um Zugang zu erhalten

Abstract

Objective

This study examined which domains/symptoms from the European Organisation for Research and Treatment of Cancer (EORTC) Quality of Life Questionnaire Core 15 Palliative (QLQ-C15-PAL), an abbreviated version of the health-related EORTC QLQ-C30 questionnaire designed for palliative cancer patients, were predictive of overall quality of life (QOL) in advanced cancer patients.

Methods

Patients with advanced cancer from six countries completed the QLQ-C15-PAL at consultation and at one follow-up point. Univariate and multivariate regression analyses were conducted to determine the predictive value of the EORTC QLQ-C15-PAL functional/symptom scores for global QOL (question 15).

Results

Three hundred forty-nine patients completed the EORTC QLQ-C15-PAL at baseline. In the total patient sample, worse emotional functioning, pain, and appetite loss were the most significant predictive factors for worse QOL. In the subgroup of patients with bone metastases (n = 240), the domains mentioned above were also the most significant predictors, whereas in patients with brain metastases (n = 109), worse physical and emotional functioning most significantly predicted worse QOL. One-month follow-up in 267 patients revealed that the significant predictors changed somewhat over time. For example, in the total patient sample, physical functioning, fatigue, and appetite loss were significant predictors at the follow-up point. A sub-analysis of predictive factors affecting QOL by primary cancer (lung, breast, and prostate) was also conducted for the total patient sample.

Conclusion

Deterioration of certain EORTC QLQ-C15-PAL functional/symptom scores significantly contributes to worse overall QOL. Special attention should be directed to managing factors most influential on overall QOL to ensure optimal management of advanced cancer patients.
Literatur
1.
Zurück zum Zitat Pastrana T, Junger S, Ostgathe C, Elsner F, Radbruch L (2008) A matter of definition—key elements identified in a discourse analysis of definitions of palliative care. Palliat Med 22:222–232PubMedCrossRef Pastrana T, Junger S, Ostgathe C, Elsner F, Radbruch L (2008) A matter of definition—key elements identified in a discourse analysis of definitions of palliative care. Palliat Med 22:222–232PubMedCrossRef
2.
3.
Zurück zum Zitat Langer CJ, Mehta MP (2005) Current management of brain metastases, with a focus on systemic options. J Clin Oncol 25:6207–6219CrossRef Langer CJ, Mehta MP (2005) Current management of brain metastases, with a focus on systemic options. J Clin Oncol 25:6207–6219CrossRef
4.
Zurück zum Zitat Pease NJ, Edwards A, Moss LJ (2005) Effectiveness of whole brain radiotherapy in the treatment of brain metastases: a systematic review. Palliat Med 19:288–99PubMedCrossRef Pease NJ, Edwards A, Moss LJ (2005) Effectiveness of whole brain radiotherapy in the treatment of brain metastases: a systematic review. Palliat Med 19:288–99PubMedCrossRef
5.
Zurück zum Zitat Tsao MN, Lloyd N, Wong R, Chow E, Rakovitch E, Laperriere N (2005) Radiotherapeutic management of brain metastases: a systematic review and meta-analysis. Cancer Treat Rev 31:256–73PubMedCrossRef Tsao MN, Lloyd N, Wong R, Chow E, Rakovitch E, Laperriere N (2005) Radiotherapeutic management of brain metastases: a systematic review and meta-analysis. Cancer Treat Rev 31:256–73PubMedCrossRef
6.
Zurück zum Zitat Dodd MJ, Miaskowski C, Paul SM (2001) Symptom clusters and their effect on the functional status of patients with cancer. Oncol Nurs Forum 28(3):465–470PubMed Dodd MJ, Miaskowski C, Paul SM (2001) Symptom clusters and their effect on the functional status of patients with cancer. Oncol Nurs Forum 28(3):465–470PubMed
7.
Zurück zum Zitat Cella DF, Tulsky DS, Gray G, Sarafian B, Linn E, Bonomi A, Silberman M, Yellen SB, Winicour P, Brannon J et al (1993) The functional assessment of cancer therapy scale: development and validation of the general measure. J Clin Oncol 11(3):570–579PubMed Cella DF, Tulsky DS, Gray G, Sarafian B, Linn E, Bonomi A, Silberman M, Yellen SB, Winicour P, Brannon J et al (1993) The functional assessment of cancer therapy scale: development and validation of the general measure. J Clin Oncol 11(3):570–579PubMed
8.
Zurück zum Zitat Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, Filiberti A, Flechtner H, Fleishman SB, de Haes JCJM et al (1993) The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 85(5):365–376PubMedCrossRef Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, Filiberti A, Flechtner H, Fleishman SB, de Haes JCJM et al (1993) The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 85(5):365–376PubMedCrossRef
9.
Zurück zum Zitat Groenvold M, Petersen MA, Aaronson NK, Arraras JI, Blazeby JM, Bottomley A, Fayers PM, de Graeff A, Hammerlid E, Kaasa S, Sprangers MA, Bjorner JB, EORTC Quality of Life Group (2006) The development of the EORTC QLQ-C15-PAL: a shortened questionnaire for cancer patients in palliative care. Eur J Cancer 42:55–64PubMedCrossRef Groenvold M, Petersen MA, Aaronson NK, Arraras JI, Blazeby JM, Bottomley A, Fayers PM, de Graeff A, Hammerlid E, Kaasa S, Sprangers MA, Bjorner JB, EORTC Quality of Life Group (2006) The development of the EORTC QLQ-C15-PAL: a shortened questionnaire for cancer patients in palliative care. Eur J Cancer 42:55–64PubMedCrossRef
10.
Zurück zum Zitat Barsevick AM, Dudley WN, Beck SL (2006) Cancer-related fatigue, depressive symptoms, and functional status: a mediation model. Nurs Res 55(5):366–372PubMedCrossRef Barsevick AM, Dudley WN, Beck SL (2006) Cancer-related fatigue, depressive symptoms, and functional status: a mediation model. Nurs Res 55(5):366–372PubMedCrossRef
11.
Zurück zum Zitat Redeker NS, Lev EL, Ruggiero J (2000) Insomnia, fatigue, anxiety, depression, and quality of life of cancer patients undergoing chemotherapy. Sch Inq Nurs Pract 14(4):275–290, discussion 291–298PubMed Redeker NS, Lev EL, Ruggiero J (2000) Insomnia, fatigue, anxiety, depression, and quality of life of cancer patients undergoing chemotherapy. Sch Inq Nurs Pract 14(4):275–290, discussion 291–298PubMed
12.
Zurück zum Zitat Visser MR, Smets EM (1998) Fatigue, depression and quality of life in cancer patients: how are they related? Support Care Cancer 6(2):101–108PubMedCrossRef Visser MR, Smets EM (1998) Fatigue, depression and quality of life in cancer patients: how are they related? Support Care Cancer 6(2):101–108PubMedCrossRef
13.
Zurück zum Zitat Niezgoda HA, Pater JL (1993) A validation study of the domains of the core EORTC Quality of Life Questionnaire. Qual Life Res 2(5):319–325PubMedCrossRef Niezgoda HA, Pater JL (1993) A validation study of the domains of the core EORTC Quality of Life Questionnaire. Qual Life Res 2(5):319–325PubMedCrossRef
14.
Zurück zum Zitat Beijer S, Kempen GIJM, Pijls-Johannesma MCG, de Graeff A, Dagnelie PC (2008) Determinants of overall quality of life in preterminal cancer patients. Int J Cancer 123(1):232–235PubMedCrossRef Beijer S, Kempen GIJM, Pijls-Johannesma MCG, de Graeff A, Dagnelie PC (2008) Determinants of overall quality of life in preterminal cancer patients. Int J Cancer 123(1):232–235PubMedCrossRef
15.
Zurück zum Zitat Ivanauskiene R, Kregzdyte R, Padaiga Z (2010) Evaluation of health-related quality of life in patients with breast cancer. Medicina (Kaunas) 46(5):351–359 Ivanauskiene R, Kregzdyte R, Padaiga Z (2010) Evaluation of health-related quality of life in patients with breast cancer. Medicina (Kaunas) 46(5):351–359
16.
Zurück zum Zitat Breivik H, Cherny N, Collett B, Conno FD, Filbet M, Foubert AJ, Cohen R, Dow L (2009) Cancer-related pain: a pan-European survey of prevalence, treatment, and patient attitudes. Ann Oncol 20(8):1420–1433PubMedCrossRef Breivik H, Cherny N, Collett B, Conno FD, Filbet M, Foubert AJ, Cohen R, Dow L (2009) Cancer-related pain: a pan-European survey of prevalence, treatment, and patient attitudes. Ann Oncol 20(8):1420–1433PubMedCrossRef
17.
Zurück zum Zitat Apolone G, Corli O, Caraceni A, Negri E, Deandrea S, Montanari M, Greco MT (2009) Pattern and quality of care of cancer pain management. Results from the Cancer Pain Outcome Research Study Group. Br J Cancer 100(10):1566–1574PubMedCrossRef Apolone G, Corli O, Caraceni A, Negri E, Deandrea S, Montanari M, Greco MT (2009) Pattern and quality of care of cancer pain management. Results from the Cancer Pain Outcome Research Study Group. Br J Cancer 100(10):1566–1574PubMedCrossRef
18.
Zurück zum Zitat Raphael J, Ahmedzai S, Hester J, Urch C, Barrie J, Williams J, Farquhar-Smith P, Fallon M, Hoskin P, Robb K (2010) Cancer pain: part 1: pathophysiology; oncological, pharmacological, and psychological treatments: a perspective from the British Pain Society endorsed by the UK Association of Palliative Medicine and the Royal College of General Practitioners. Pain Med 11(5):742–764PubMedCrossRef Raphael J, Ahmedzai S, Hester J, Urch C, Barrie J, Williams J, Farquhar-Smith P, Fallon M, Hoskin P, Robb K (2010) Cancer pain: part 1: pathophysiology; oncological, pharmacological, and psychological treatments: a perspective from the British Pain Society endorsed by the UK Association of Palliative Medicine and the Royal College of General Practitioners. Pain Med 11(5):742–764PubMedCrossRef
19.
Zurück zum Zitat Zhu J, Davis RB, Stuver SO, Berry DL, Block S, Weeks JC, Weingart SN (2012) A longitudinal study of pain variability and its correlates in ambulatory patients with advanced stage cancer. Cancer 118:6278–6286 Zhu J, Davis RB, Stuver SO, Berry DL, Block S, Weeks JC, Weingart SN (2012) A longitudinal study of pain variability and its correlates in ambulatory patients with advanced stage cancer. Cancer 118:6278–6286
20.
Zurück zum Zitat Kawaguchi T, Iwase S, Koinuma M, Onodera Y, Takeuchi H, Umeda M, Matsunaga T, Unezaki S, Nagumo Y (2012) Determinants affecting quality of life: implications for pharmacist counseling for patients with breast cancer in Japan. Biol Pharm Bull 35(1):59–64PubMedCrossRef Kawaguchi T, Iwase S, Koinuma M, Onodera Y, Takeuchi H, Umeda M, Matsunaga T, Unezaki S, Nagumo Y (2012) Determinants affecting quality of life: implications for pharmacist counseling for patients with breast cancer in Japan. Biol Pharm Bull 35(1):59–64PubMedCrossRef
21.
Zurück zum Zitat Lue BH, Huang TS, Chen HJ (2008) Physical distress, emotional status, and quality of life in patients with nasopharyngeal cancer complicated by post-radiotherapy endocrinopathy. Int J Radiat Oncol Biol Phys 70(1):28–34PubMedCrossRef Lue BH, Huang TS, Chen HJ (2008) Physical distress, emotional status, and quality of life in patients with nasopharyngeal cancer complicated by post-radiotherapy endocrinopathy. Int J Radiat Oncol Biol Phys 70(1):28–34PubMedCrossRef
22.
Zurück zum Zitat van den Beuken-van Everdingen MHJ, Janneke M, de Rijke JM, Kessels AG, Schouten HC, van Kleef M, Patijn J (2009) Quality of life and non-pain symptoms in patients with cancer. J Pain Symptom Manag 38(2):216–233CrossRef van den Beuken-van Everdingen MHJ, Janneke M, de Rijke JM, Kessels AG, Schouten HC, van Kleef M, Patijn J (2009) Quality of life and non-pain symptoms in patients with cancer. J Pain Symptom Manag 38(2):216–233CrossRef
23.
Zurück zum Zitat Capuano G, Gentile PC, Bianciardi F, Tosti M, Palladino A, Di Palma M (2010) Prevalence and influence of malnutrition on quality of life and performance status in patients with locally advanced head and neck cancer before treatment. Support Care Cancer 18(4):433–437PubMedCrossRef Capuano G, Gentile PC, Bianciardi F, Tosti M, Palladino A, Di Palma M (2010) Prevalence and influence of malnutrition on quality of life and performance status in patients with locally advanced head and neck cancer before treatment. Support Care Cancer 18(4):433–437PubMedCrossRef
24.
Zurück zum Zitat O’Gorman O, Mcmillan DC, McArdle CS (1998) Impact of weight loss, appetite, and the inflammatory response on quality of life in gastrointestinal cancer patients. Nutr Cancer 32(2):76–80PubMedCrossRef O’Gorman O, Mcmillan DC, McArdle CS (1998) Impact of weight loss, appetite, and the inflammatory response on quality of life in gastrointestinal cancer patients. Nutr Cancer 32(2):76–80PubMedCrossRef
25.
Zurück zum Zitat Droney J, Ross J, Gretton S, Welsh K, Sato H, Riley J (2008) Constipation in cancer patients on morphine. Support Care Cancer 16(5):453–459PubMedCrossRef Droney J, Ross J, Gretton S, Welsh K, Sato H, Riley J (2008) Constipation in cancer patients on morphine. Support Care Cancer 16(5):453–459PubMedCrossRef
26.
Zurück zum Zitat Mancini I, Bruera E (1998) Constipation in advanced cancer patients. Support Care Cancer 6(4):356–364PubMedCrossRef Mancini I, Bruera E (1998) Constipation in advanced cancer patients. Support Care Cancer 6(4):356–364PubMedCrossRef
27.
Zurück zum Zitat Barnes EA, Bruera E (2002) Fatigue in patients with advanced cancer: a review. Int J Gynecol Cancer 12:424–428PubMedCrossRef Barnes EA, Bruera E (2002) Fatigue in patients with advanced cancer: a review. Int J Gynecol Cancer 12:424–428PubMedCrossRef
28.
Zurück zum Zitat Wagner LI, Cella D (2004) Fatigue and cancer: causes, prevalence and treatment approaches. Br J Cancer 91:822–828PubMed Wagner LI, Cella D (2004) Fatigue and cancer: causes, prevalence and treatment approaches. Br J Cancer 91:822–828PubMed
29.
Zurück zum Zitat Zeng L, Koo K, Zhang L, Jon F, Dennis K, Holden L, Nguyen J, Tsao M, Barnes E, Danjoux C et al (2012) Fatigue in advanced cancer patients attending an outpatient palliative radiotherapy clinic as screened by the Edmonton Symptom Assessment System. Support Care Cancer 20(5):1037–1042PubMedCrossRef Zeng L, Koo K, Zhang L, Jon F, Dennis K, Holden L, Nguyen J, Tsao M, Barnes E, Danjoux C et al (2012) Fatigue in advanced cancer patients attending an outpatient palliative radiotherapy clinic as screened by the Edmonton Symptom Assessment System. Support Care Cancer 20(5):1037–1042PubMedCrossRef
30.
Zurück zum Zitat Yennurajalingam S, Palmer JL, Zhang T et al (2008) Association between fatigue and other cancer-related symptoms in patients with advanced cancer. Support Care Cancer 16:1125–1130PubMedCrossRef Yennurajalingam S, Palmer JL, Zhang T et al (2008) Association between fatigue and other cancer-related symptoms in patients with advanced cancer. Support Care Cancer 16:1125–1130PubMedCrossRef
Metadaten
Titel
Predictive factors for overall quality of life in patients with advanced cancer
verfasst von
Gemma Cramarossa
Edward Chow
Liying Zhang
Gillian Bedard
Liang Zeng
Arjun Sahgal
Vassilios Vassiliou
Takefumi Satoh
Palmira Foro
Brigette B. Y. Ma
Wei-Chu Chie
Emily Chen
Henry Lam
Andrew Bottomley
Publikationsdatum
01.06.2013
Verlag
Springer-Verlag
Erschienen in
Supportive Care in Cancer / Ausgabe 6/2013
Print ISSN: 0941-4355
Elektronische ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-013-1717-7

Weitere Artikel der Ausgabe 6/2013

Supportive Care in Cancer 6/2013 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.